Arca Biopharma sell StockNews.com
Start price
22.12.23
/
50%
€1.51
Target price
22.12.24
-
Performance (%)
116.61%
Price
17:36
€3.26
Summary
This prediction is currently active. The price for Arca Biopharma has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 22.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | 9.333% | 9.333% |
iShares Core DAX® | -0.448% | 2.344% |
iShares Nasdaq 100 | 0.834% | 5.019% |
iShares Nikkei 225® | -0.479% | 0.550% |
iShares S&P 500 | -0.352% | 2.631% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat